samedan logo

home > pmps > winter 2004 > targeted and controlled release of cytotoxic agents: progress and obstacles towards the elusive ‘magic bullets’ for cancer


Dear guest!

article: Targeted and Controlled Release of Cytotoxic Agents: Progress and Obstacles towards the Elusive ‘Magic Bullets’ for Cancer
format: Adobe Acrobat PDF file
cost: £


News and Press Releases

Evonetix Commences Early Access Program for DNA Synthesised by Thermal Control on its Semiconductor Chip

Cambridge, UK 16th August 2022 – EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the opening of its early access program for semiconductor synthesised DNA. Evonetix’s DNA synthesis capability brings together patented semiconductor chip design and proprietary, thermally controlled synthesis chemistry, which will be integral to the Company’s future gene synthesis platforms.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement